Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer (FORTIS-C)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by Agennix.
Recruitment status was  Recruiting
Information provided by (Responsible Party):
Agennix Identifier:
First received: June 26, 2008
Last updated: March 13, 2012
Last verified: March 2012
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2016
  Estimated Primary Completion Date: June 2015 (Final data collection date for primary outcome measure)